MyAverix Finance
SHG · Healthcare
Mabwell (Shanghai) Bioscience Co. Ltd. A (688062)
Biotechnology
Mabwell (Shanghai) Bioscience Co. Ltd. A (688062) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $14.51B, P/E ratio is 18.00, net margin is -146.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688062
Mabwell (Shanghai) Bioscience Co. Ltd. A (688062) — FAQ
What is Mabwell (Shanghai) Bioscience Co. Ltd. A's market cap?
Mabwell (Shanghai) Bioscience Co. Ltd. A (688062) has a reported market cap of $14.51B (data as of 2026-03-29).
What is 688062's P/E ratio?
The price-to-earnings (P/E) ratio for Mabwell (Shanghai) Bioscience Co. Ltd. A (688062) is 18.00 (data as of 2026-03-29).
Does Mabwell (Shanghai) Bioscience Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Mabwell (Shanghai) Bioscience Co. Ltd. A (688062). Check the MyAverix Finance app for the latest dividend data.
What sector is Mabwell (Shanghai) Bioscience Co. Ltd. A in?
Mabwell (Shanghai) Bioscience Co. Ltd. A (688062) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688062 listed on?
688062 is listed on SHG.
What is Mabwell (Shanghai) Bioscience Co. Ltd. A's net margin?
Mabwell (Shanghai) Bioscience Co. Ltd. A (688062) reports a net margin of -146.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.